Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer

Enzyme and Microbial Technology

Volumn 50, Issue 3, 2012, Pages 173-180

  Baek, J O ^a,b   Seo, J W ^a   Kwon, O ^a   Park, S M ^c   Kim, C H ^a   Kim, I H ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Antigen delivery system; Bacillus subtilis; Cervical cancer; Human papillomavirus (HPV); Virus like particle (VLP)

Indexed keywords

ANTIGEN DELIVERY SYSTEM; BACILLUS SUBTILIS; CERVICAL CANCERS; HUMAN PAPILLOMAVIRUS; VIRUS-LIKE PARTICLES;

ANTIGENS; BACILLI; BACTERIOLOGY; CENTRIFUGATION; COLUMN CHROMATOGRAPHY; DISEASES; ESCHERICHIA COLI; GENE ENCODING; ONCOGENIC VIRUSES; PURIFICATION; SODIUM CHLORIDE; SUGAR (SUCROSE); VACCINES;

PROTEINS;

CAPSID PROTEIN; VIRUS DNA; VIRUS LIKE PARTICLE VACCINE; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; FEMALE; GENE ACTIVITY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS LIKE AGENT; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; BACILLUS SUBTILIS; BIOTECHNOLOGY; CAPSID PROTEINS; FEMALE; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RECOMBINANT PROTEINS; UTERINE CERVICAL NEOPLASMS; VIRION;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 33; MIRIDAE; NEGIBACTERIA;

EID: 84856461874     PISSN: 01410229     EISSN: 18790909     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2011.11.004     Document Type: Article

References (40)

1. Kim S.H., Choi N.S. Purification and characterization of subtilisin DJ-4 secreted by Bacillus sp. strain DJ-4 screened from Doen-Jang. Biosci Biotechnol Biochem 2000, 64:1722-1725.
2. Kim T.W., Lee J.H., Kim S.E., Park M.H., Chang H.C., Kim H.Y. Analysis of microbial communities in doenjang, a Korean fermented soybean paste, using nested PCR-denaturing gradient gel electrophoresis. Int J Food Microbiol 2009, 131:265-271.
3. Cho S.J., Oh S.H., Pridmore R.D., Juillerat M.A., Lee C.H. Purification and characterization of proteases from Bacillus amyloliquefaciens isolated from traditional soybean fermentation starter. J Agric Food Chem 2003, 51:7664-7670.
4. Ohmura K., Shiroza T., Nakamura K., Nakayama A., Yamane K., Yoda K., et al. A Bacillus subtilis secretion vector system derived from the B. subtilis alpha-amylase promoter and signal sequence region, and secretion of Escherichia coli beta-lactamase by the vector system. J Biochem 1984, 95:87-93.
5. Tanaka T., Kawano N. Cloning vehicles for the homologous Bacillus subtilis host-vector system. Gene 1980, 10:131-136.
6. Errington J. Efficient Bacillus subtilis cloning system using bacteriophage vector phi 105J9. J Gen Microbiol 1984, 130:2615-2628.
7. Dunny G.M., Lee L.N., LeBlanc D.J. Improved electroporation and cloning vector system for gram-positive bacteria. Appl Environ Microbiol 1991, 57:1194-1201.
8. Chang S., Cohen S.N. High frequency transformation of Bacillus subtilis protoplasts by plasmid DNA. Mol Gen Genet 1979, 168:111-115.
9. Anagnostopoulos C., Spizizen J. Requirements for transformation in Bacillus subtilis. J Bacteriol 1961, 81:741-746.
10. Vehmaanpera J. Transformation of Bacillus amyloliquefaciens by electroporation. FEMS Microbiol Lett 1989, 52:165-169.
11. Mauriello E.M., Duc le H., Isticato R., Cangiano G., Hong H.A., De Felice M., et al. Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner. Vaccine 2004, 22:1177-1187.
12. Fu L.L., Li W.F., Du H.H., Dai W., Xu Z.R. Oral vaccination with envelope protein VP28 against white spot syndrome virus in Procambarus clarkii using Bacillus subtilis as delivery vehicles. Lett Appl Microbiol 2008, 46:581-586.
13. Zhou Z., Xia H., Hu X., Huang Y., Li Y., Li L., et al. Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3kDa confers protection against Clonorchis sinensis. Vaccine 2008, 26:1817-1825.
14. Paccez J.D., Nguyen H.D., Luiz W.B., Ferreira R.C., Sbrogio-Almeida M.E., Schuman W., et al. Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Vaccine 2007, 25:4671-4680.
15. Schiller J.T., Lowy D.R. Papillomavirus-like particles and HPV vaccine development. Semin Cancer Biol 1996, 7:373-382.
16. Baek J.O., Seo J.W., Kim I.H., Kim C.H. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography. Protein Expr Purif 2011, 75:211-217.
17. Aires K.A., Cianciarullo A.M., Carneiro S.M., Villa L.L., Boccardo E., Perez-Martinez G., et al. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells. Appl Environ Microbiol 2006, 72:745-752.
18. Buck C.B., Thompson C.D., Pang Y.Y., Lowy D.R., Schiller J.T. Maturation of papillomavirus capsids. J Virol 2005, 79:2839-2846.
19. Rose R.C., Bonnez W., Da Rin C., McCance D.J., Reichman R.C. Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. J Gen Virol 1994, 75(Pt 9):2445-2449.
20. Modis Y., Trus B.L., Harrison S.C. Atomic model of the papillomavirus capsid. EMBO J 2002, 21:4754-4762.
21. Bishop B., Dasgupta J., Chen X.S. Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly. Virol J 2007, 4:3.
22. Palmer K.E., Jenson A.B., Kouokam J.C., Lasnik A.B., Ghim S.J. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer. Exp Mol Pathol 2009, 86:224-233.
23. Xu Y.F., Zhang Y.Q., Xu X.M., Song G.X. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes. Arch Virol 2006, 151:2133-2148.
24. Senger T., Schadlich L., Gissmann L., Muller M. Enhanced papillomavirus-like particle production in insect cells. Virology 2009, 388:344-353.
25. Seo P.S., Heo S.Y., Han E.J., Seo J.W., Ghim S.J., Kim C.H. Bacterial expression and purification of human papillomavirus type 18 L1. Biotechnol Bioprocess Eng 2009, 14:168-174.
26. Bazan S.B., de Alencar Muniz Chaves A., Aires K.A., Cianciarullo A.M., Garcea R.L., Ho P.L. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Arch Virol 2009, 154:1609-1617.
27. Kim S.N., Jeong H.S., Park S.N., Kim H.J. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. J Virol Methods 2007, 139:24-30.
28. Park M.A., Kim H.J. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr Purif 2008, 59:175-181.
29. Woo M.K., An J.M., Kim J.D., Park S.N., Kim H.J. Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae. Arch Pharm Res 2008, 31:205-209.
30. Kim H.J., Kim S.Y., Lim S.J., Kim J.Y., Lee S.J. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr Purif 2010, 70:68-74.
31. Sasagawa T., Tani M., Basha W., Rose R.C., Tohda H., Giga-Hama Y., et al. A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Res 2005, 110:81-90.
32. Liu H.L., Li W.S., Lei T., Zheng J., Zhang Z., Yan X.F., et al. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. Acta Biochim Biophys Sin (Shanghai) 2005, 37:153-158.
33. Mason H.S., Warzecha H., Mor T., Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002, 8:324-329.
34. Warzecha H., Mason H.S., Lane C., Tryggvesson A., Rybicki E., Williamson A.L., et al. Oral immunogenicity of human papillomavirus-like particles expressed in potato. J Virol 2003, 77:8702-8711.
35. Poo H., Pyo H.M., Lee T.Y., Yoon S.W., Lee J.S., Kim C.J., et al. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer 2006, 119:1702-1709.
36. Mach H., Volkin D.B., Troutman R.D., Wang B., Luo Z., Jansen K.U., et al. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J Pharm Sci 2006, 95:2195-2206.
37. Steinmetz M., Richter R. Easy cloning of mini-Tn10 insertions from the Bacillus subtilis chromosome. J Bacteriol 1994, 176:1761-1763.
38. Rose R.C., Reichman R.C., Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol 1994, 75(Pt 8):2075-2079.
39. Schenck S., Kehm E., Epstein A.L., Zentgraf H., Muller M., Knopf C.W. Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors. Virus Genes 2008, 37:131-143.
40. Kim E.J., Yoo S.K. Cell surface display of hepatitis B virus surface antigen by using Pseudomonas syringae ice nucleation protein. Lett Appl Microbiol 1999, 29:292-297.